Robert Mittendorff, MD
Norwest Venture Partners
Dr. Mittendorff focuses on investing capital in venture and growth opportunities in the healthcare sector. He has been involved in investments with public equity value or acquisitions that exceed $5B. He is a board certified emergency physician and former public company operating executive with experience that spans investing, complex business development transactions, the leadership of clinical advisory boards, product development, clinical trials, commercial activities, and clinical services management. He is a Fellow of the American Academy of Emergency Medicine (FAAEM).
At Norwest he focuses on investing in category defining companies in healthcare led by exceptional leadership teams.
He currently serves on the boards of Impel, Qventus, Silk Road Medical (SILK), TigerConnect, and VisitPay, and Neocis and is a board observer at Talkspace, Omada, and Route92. He was a board member at iCardiac (acq. by eResearch), Telcare (acq. by BioTelemetry) and was a board observer at Crossover (acq. by Gurnet). Robert was a previous board observer at Intersect ENT (Nasdaq: XENT), and iRhythm Technologies (Nasdaq: IRTC). Dr. Mittendorff was involved with the initial investments in Misfit Wearables (acq. by Fossil) and Health Catalyst (HCAT).
Dr. Mittendorff was co-chair of the Digital Healthcare Innovation Summit and was a member of the Leadership Fellows at Johns Hopkins.
Prior to Norwest, Dr. Mittendorff was an executive officer and the Vice President of Marketing and Business Development at Hansen Medical Inc. (Nasdaq: HNSN, acquired by Auris, Auris acquired by JNJ for $3.5B in ‘19). He launched multiple products including the Magellan & Sensei X robots and led the Company’s partnerships with GE, Siemens, Philips and St. Jude Medical In transactions above $100M. He created the SAB and pitched in a $30M public financing.
Dr. Mittendorff has also worked in portfolio strategy at Merck and as a management consultant at BCG. He is a Harvard / Stanford trained physician who received his M.B.A from Harvard and his B.S. in biomedical engineering from Johns Hopkins where he was a varsity athlete. He has completed fellowships with Howard Hughes, MIT and HBS.